Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
Authors
Keywords
-
Journal
Molecular Cancer
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-01
DOI
10.1186/s12943-021-01371-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies
- (2021) Sumeng Wang et al. Molecular Cancer
- Detection of epidermal growth factor receptor mutations in peripheral blood circulating tumor DNA in patients with advanced non-small cell lung cancer
- (2020) Shunkai Zhou et al. MEDICINE
- Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer
- (2020) Yi-Long Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
- (2019) Zhijie Wang et al. JAMA Oncology
- Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
- (2019) Gabriele De Rubis et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer
- (2019) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer
- (2019) Peter G. Hawkins et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium
- (2019) B T Li et al. ANNALS OF ONCOLOGY
- Circulating long non‐coding RNA GAS5 and SOX2OT as potential biomarkers for diagnosis and prognosis of non‐small cell lung cancer
- (2019) Lamiaa M. Kamel et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer
- (2019) Natasha B. Leighl et al. CLINICAL CANCER RESEARCH
- Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
- (2019) Vincent P Groot et al. CLINICAL CANCER RESEARCH
- A combined panel of circulating microRNA as a diagnostic tool for detection of the non-small cell lung cancer
- (2019) A Abdollahi et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Circulating MicroRNAs in Cancer: Potential and Challenge
- (2019) Mengying Cui et al. Frontiers in Genetics
- Perioperative dynamic changes in circulating tumor DNA in lung cancer patients (DYNAMIC)
- (2019) Kezhong Chen et al. CLINICAL CANCER RESEARCH
- Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
- (2019) Andrew Georgiadis et al. CLINICAL CANCER RESEARCH
- Exosomal long non‑coding RNA DLX6‑AS1 as a potential diagnostic biomarker for non‑small cell lung cancer
- (2019) Xilin Zhang et al. Oncology Letters
- LBA83Final efficacy results from B-F1RST, a prospective phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC)
- (2019) M Socinski et al. ANNALS OF ONCOLOGY
- Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
- (2019) Suresh S. Ramalingam et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer
- (2019) Rohan Gupta et al. ONCOLOGIST
- Circulating plasma lncRNAs as novel markers ofEGFRmutation status and monitors of epidermal growth factor receptor‐tyrosine kinase inhibitor therapy
- (2019) Panpan Lv et al. Thoracic Cancer
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
- (2019) Jeanne Tie et al. JAMA Oncology
- Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer
- (2018) N Guibert et al. ANNALS OF ONCOLOGY
- The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma
- (2018) Mantang Qiu et al. CANCER RESEARCH
- Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
- (2018) Sarah B. Goldberg et al. CLINICAL CANCER RESEARCH
- False positive plasma genotyping due to clonal hematopoiesis
- (2018) Yuebi Hu et al. CLINICAL CANCER RESEARCH
- Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR -Mutant Lung Adenocarcinoma
- (2018) Álvaro Taus et al. Clinical Lung Cancer
- The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities
- (2018) Ivan A. Zaporozhchenko et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- IASLC Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC)
- (2018) Christian Rolfo et al. Journal of Thoracic Oncology
- Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer
- (2018) Yujiao Xie et al. Molecular Oncology
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
- (2018) Hao Wang et al. Clinical Epigenetics
- A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer
- (2018) Dong Hang et al. Cancer Medicine
- Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies
- (2018) Jenny H. Lee et al. JAMA Oncology
- Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer
- (2018) Wei Peng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
- (2018) David R. Gandara et al. NATURE MEDICINE
- Sequencing of Circulating Cell-free DNA during Pregnancy
- (2018) Diana W. Bianchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- (2018) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer
- (2018) Joseph Sparano et al. JAMA Oncology
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
- (2018) Charu Aggarwal et al. JAMA Oncology
- Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component
- (2017) James Chih-Hsin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of plasma to tissue DNA mutations in surgical patients with non–small cell lung cancer
- (2017) Kezhong Chen et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- CircRNA: functions and properties of a novel potential biomarker for cancer
- (2017) Shujuan Meng et al. Molecular Cancer
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- A comprehensive profile of circulating RNAs in human serum
- (2017) Sinan Uğur Umu et al. RNA Biology
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
- (2017) Aadel A. Chaudhuri et al. Cancer Discovery
- An emerging function of circRNA-miRNAs-mRNA axis in human diseases
- (2017) Dawei Rong et al. Oncotarget
- Identifying and Characterizing circRNA-Protein Interaction
- (2017) William W Du et al. Theranostics
- High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer
- (2017) Xiaoxiao Xu et al. Cancer Medicine
- High Throughput Sequencing of Extracellular RNA from Human Plasma
- (2017) Kirsty M. Danielson et al. PLoS One
- Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
- (2016) M. Jamal-Hanjani et al. ANNALS OF ONCOLOGY
- Circulating Long RNAs in Serum Extracellular Vesicles: Their Characterization and Potential Application as Biomarkers for Diagnosis of Colorectal Cancer
- (2016) L. Dong et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
- (2016) S. Ortiz-Cuaran et al. CLINICAL CANCER RESEARCH
- Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
- (2016) Glenwood Goss et al. LANCET ONCOLOGY
- Rapid clearance of circulating tumor DNA during treatment with AZD9291 of a lung cancer patient presenting the resistance EGFR T790M mutation
- (2016) Audrey Vallée et al. LUNG CANCER
- Small non-coding RNA biomarkers in sputum for lung cancer diagnosis
- (2016) Yun Su et al. Molecular Cancer
- Integrated digital error suppression for improved detection of circulating tumor DNA
- (2016) Aaron M Newman et al. NATURE BIOTECHNOLOGY
- Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression
- (2016) Wen Cai Zhang et al. Nature Communications
- Circulating tumor DNA detection in lung cancer patients before and after surgery
- (2016) Nannan Guo et al. Scientific Reports
- First-line erlotinib versus gemcitabine/cisplatin in patients with advancedEGFRmutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study
- (2015) Y.-L. Wu et al. ANNALS OF ONCOLOGY
- Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
- (2015) T. Mok et al. CLINICAL CANCER RESEARCH
- Digital quantification of miRNA directly in plasma using integrated comprehensive droplet digital detection
- (2015) Kaixiang Zhang et al. LAB ON A CHIP
- The landscape of long noncoding RNAs in the human transcriptome
- (2015) Matthew K Iyer et al. NATURE GENETICS
- Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
- (2015) Kenneth S Thress et al. NATURE MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
- (2015) Muhammed Murtaza et al. Nature Communications
- Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer
- (2015) R. Jonas A. Nilsson et al. Oncotarget
- OncomiR detection in circulating body fluids: a PDMS microdevice perspective
- (2014) Cristina Potrich et al. LAB ON A CHIP
- Detecting and characterizing circular RNAs
- (2014) William R Jeck et al. NATURE BIOTECHNOLOGY
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Detecting ultralow-frequency mutations by Duplex Sequencing
- (2014) Scott R Kennedy et al. Nature Protocols
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study
- (2013) J-Y Douillard et al. BRITISH JOURNAL OF CANCER
- Quantification of Circulating miRNAs in Plasma
- (2013) Ioanna S. Sourvinou et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- Differential Plasma MicroRNA Profiles in HBeAg Positive and HBeAg Negative Children with Chronic Hepatitis B
- (2013) Thilde Nordmann Winther et al. PLoS One
- Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy
- (2012) En-hai Cui et al. ACTA PHARMACOLOGICA SINICA
- Quantitative analysis of free-circulating DNA in plasma of patients with resectable NSCLC
- (2012) Adam Szpechcinski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
- (2012) Luis A. Diaz Jr et al. NATURE
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
- (2012) Hongjiang Wang et al. PLoS One
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
- (2011) Fanfei Kong et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
- (2011) Radha Duttagupta et al. PLoS One
- Detection and quantification of rare mutations with massively parallel sequencing
- (2011) I. Kinde et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long noncoding RNAs and human disease
- (2011) Orly Wapinski et al. TRENDS IN CELL BIOLOGY
- Circulating Benign Nevus Cells Detected by ISET Technique
- (2010) Vincenzo De Giorgi et al. ARCHIVES OF DERMATOLOGY
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer
- (2010) Zhibin Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
- (2010) Jipei Liao et al. Molecular Cancer
- Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells
- (2010) Lucy Pigati et al. PLoS One
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Long noncoding RNAs: functional surprises from the RNA world
- (2009) J. E. Wilusz et al. GENES & DEVELOPMENT
- Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer
- (2009) Ying Xie et al. LUNG CANCER
- Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
- (2009) Mitchell Guttman et al. NATURE
- A SNP in a let-7 microRNA Complementary Site in the KRAS 3' Untranslated Region Increases Non-Small Cell Lung Cancer Risk
- (2008) L. J. Chin et al. CANCER RESEARCH
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now